⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11148332 | 0.84 | F2 (0.35) | — | |
| SCHEMBL9115818 | 0.76 | — | — | |
| SCHEMBL3468212 | 0.76 | — | — | |
| SCHEMBL55042 | 0.76 | — | — | |
| SCHEMBL6987500 | 0.73 | — | — | |
| SCHEMBL15808459 | 0.73 | TSHR (0.32) | — | |
| SCHEMBL1728266 | 0.71 | — | — | |
| SCHEMBL18301294 | 0.71 | — | — | |
| SCHEMBL6570211 | 0.71 | TSHR (0.30) | — | |
| SCHEMBL6633090 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110586445-A | Production and manufacturing process of modified black epoxy hydrophilic aluminum foil | 黄山天马铝业有限公司 | 2019-12-20 | — | — | CN | claimed |
| CN-102464701-B | One class novel cpd, Preparation Method And The Use | SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) | 2015-10-21 | — | — | CN | claimed |
| US-8691859-B2 | Broad spectrum antibacterial compounds | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2014-04-08 | — | — | US | claimed |
| EP-2069288-B1 | TARTRATE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS | SANOFI SA (FR) | 2014-03-26 | — | — | EP | claimed |
| CN-101516833-B | Tartaric acid derivatives as coagulation factor IXa inhibitors | SANOFI AVENTIS | 2013-04-03 | — | — | CN | claimed |
| US-8263621-B2 | Tartrate derivatives for use as coagulation factor IXa inhibitors | SANOFI (FR) | 2012-09-11 | — | — | US | claimed |
| CN-102464701-A | Novel compound, preparation method and application thereof | SHANGHAI INST PHARM INDUSTRY | 2012-05-23 | — | — | CN | claimed |
| US-20110086877-A1 | Small Molecule Inhibitors of Botulinum Neurotoxins | BAVARI SINA | 2011-04-14 | — | — | US | claimed |
| US-20090233961-A1 | TARTRATE DERIVATIVES FOR USE AS COAGULATION FACTOR IXA INHIBITORS | SANOFI-AVENTIS (FR) | 2009-09-17 | — | — | US | claimed |
| CN-101516833-A | Tartaric acid derivatives as coagulation factor IXa inhibitors | SANOFI AVENTIS (FR) | 2009-08-26 | — | — | CN | claimed |
| JP-H08505862-A | — | — | 1996-06-25 | — | — | JP | claimed |
| WO-1996007648-A1 | 2-SUBSTITUTED-4H-3,1-BENZOXAZIN-4-ONES AND BENZTHIAZIN-4-ONES AS INHIBITORS OF COMPLEMENT Clr PROTEASE FOR THE TREATMENT OF INFLAMMATORY PROCESSES | WARNER-LAMBERT COMPANY (US) | 1996-03-14 | — | — | WO | claimed |
| WO-1996002514-A1 | UREA AND CARBAMIC ACID DERIVATIVES, DRUGS CONTAINING THESE COMPOUNDS, AND PROCESS FOR THEIR PREPARATION | DR. KARL THOMAE GMBH (DE) | 1996-02-01 | — | — | WO | claimed |
| EP-0680469-A1 | AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME | Dr. Karl Thomae GmbH (DE) | 1995-11-08 | — | — | EP | claimed |
| EP-0680332-A1 | COMBINATION OF A SOLUBLE COMPLEMENT RECEPTOR -1(SCR1) AND AN AMIDINOPHENYL OR AMIDINO NAPHTHYL-ESTER FOR TREATING INFLAMMATION | SMITHKLINE BEECHAM PLC (GB) | 1995-11-08 | — | — | EP | claimed |
| WO-1995007291-A1 | KININOGEN INHIBITORS | FERRING B.V. (NL) | 1995-03-16 | — | — | WO | claimed |
| WO-1994016719-A1 | COMBINATION OF A SOLUBLE COMPLEMENT RECEPTOR -1(SCR1) AND AN AMIDINOPHENYL OR AMIDINO NAPHTHYL-ESTER FOR TREATING INFLAMMATION | SMITHKLINE BEECHAM PLC (GB) | 1994-08-04 | — | — | WO | claimed |
| WO-1994017035-A1 | AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME | DR. KARL THOMAE GMBH (DE) | 1994-08-04 | — | — | WO | claimed |
| EP-0384362-A2 | Glycinderivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1990-08-29 | — | — | EP | claimed |
| US-4889860-A | ANALGESICS, ANTISHOCK AGENTS, DIETETICS, ANTIHALLUCINOGENS; SIDE EFFECT REDUCTION | NOVA PHARMACEUTICAL CORPORATION (US) | 1989-12-26 | — | — | US | claimed |